...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Classifying/taxonomy mCRPC patients

Predicting accurately exactly which patients will respond to treatment is the foundation of Champions Oncology translational program. The symbol is CSBR; Constellation may be a client of theirs, I dont know. Many Pharmas are clients. Worth a look for sure.

 

 

 

 

Share
New Message
Please login to post a reply